Why the study?
Does persistent pulmonary vascular obstruction on 6-month CTPA predict long-term death or VTE recurrence in patients with acute pulmonary embolism?
Does persistent pulmonary vascular obstruction on 6-month CTPA predict long-term death or VTE recurrence in patients with acute pulmonary embolism?
Persistent pulmonary vascular obstruction on CTPA 6 months after acute PE does not appear to predict long-term risk of death or recurrent VTE.
Residual obstruction on 6-month CTPA does not predict long-term death or VTE recurrence after PE; leaves open the prognostic value of follow-up imaging.
BACKGROUND: The incidence and clinical significance of pulmonary residual thrombosis 6 months after an acute pulmonary embolism (PE) are still not well-known. PURPOSE: To evaluate the association between residual vascular obstruction and the risk of venous thromboembolism (VTE) recurrence or death. MATERIAL AND METHODS: Computed tomography pulmonary angiography (CTPA) was repeated in 97 consecutive patients 6 months after an acute episode of hemodynamically stable pulmonary embolism. We assessed the long-term consequences of residual thrombosis on vital status and incidence of recurrent VTE. RESULTS: Six patients were lost for follow-up. The remaining 91 patients were classified according to the presence (Group 1: 18 cases) or absence (Group 2: 73 cases) of residual pulmonary vascular obstruction. After a mean ± SD of 2.91 ± 0.99 years, there were eight (8.8%) deaths and 11 (12.1%) VTE recurrences. Groups 1 and 2 did not differ in the incidence of death or VTE recurrence. CONCLUSION: Persistent pulmonary vascular obstruction on 6-month CTPA did not predict long-term adverse outcome events.
No takes yet. Share an insight, caveat, or question.
Golpe et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: